Changing the way we view and
approach our overall health and wellness
We are a 501c4 organization focused on bills in Washington State
for the legalization of plant medicines.
Research demonstrates that natural psychedelic medicines are a non-addictive tool
that show promise in treating mental health conditions — including for veterans struggling with PTSD
and terminally ill patients facing depression because of their diagnosis.
Legal access to therapeutic plant medicines will help more Washingtonians find the relief and peace they need in a supervised setting.
Matthew W. Johnson, CC BY-SA 3.0 https://creativecommons.org/licenses/by-sa/3.0 , via Wikimedia Commons
Salomon’s Psilocybin Bill and Ibogaine Bill for WA State, more info coming soon!
The bills are now on the legislature’s website. People can follow the bills’ status and also submit comments to their legislators via a button.
Washington State Legislature: SB 5201 – 2025-26 Concerning access to psychedelic substances
Washington State Legislature: SB 5204 – 2025-26 Concerning ibogaine-assisted therapy.
About the SB 5201 Bill:
- Permits adult only use, supervised by licensed professionals.
- Not de-crim. No retail stores. No ability for people to consume recreationally.
- Creates an opportunity for military veterans to find relief from PTSD.
- Equity, costs, safety, and access were considered in all aspects of this bill.
- Offers experimental treatment and research for Opioid Use Disorder.
- Works in collaboration with the University of Washington.
- The program contributes significantly to ongoing research efforts.
- Drafted to be a self-funding program.
- We hired the lawyers who wrote the Oregon and Colorado initiatives and had them fix prior shortcomings.
- We consulted with and hired numerous experts, doctors, and practitioners to help design this bill.
- Washington has taken best-practices from around the world to develop a world-class bill. Washington can be a leader for other states.
Please donate and help us reach our fundraising goal!
Safety-Centered and Regulated
This bill seeks to create regulated access to natural psilocybin in a therapeutic setting for adults dealing with mental health challenges such as depression, anxiety, and overall mental well-being. It prioritizes safety by permitting adults aged 21 and older to use these research-backed treatments under the supervision of licensed facilitators. These services will be provided at licensed healing centers and approved healthcare facilities.
Supported by Research
Natural psychedelic medicines are non-addictive and provide substantial benefits for individuals facing difficult mental health conditions like depression and anxiety, as well as for those seeking comfort at the end of life. Prominent research institutions, including Johns Hopkins, UCLA, and NYU, have studied these therapies. The FDA has recognized psilocybin, a natural psychedelic, as a “breakthrough therapy” due to its effectiveness in treating treatment-resistant depression when other approaches have not succeeded.
Johns Hopkins Medicine researchers report that two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms
Psychedelic Treatment with Psilocybin Relieves Major Depression, Study Shows, November 4, 2020 … Read More
Psychedelic compounds … have shown significant promise in treating a range of mental health disorders, with participants in clinical studies often describing tremendous progress taming the demons of post-traumatic stress disorder, or finding unexpected calm and clarity as they face a terminal illness.
Psilocybin Spurs Brain Activity in Patients With Depression, Small Study Shows, April 11, 2022 … Read More
Colorado Governor Jared Polis discussed with Bill Maher why he supports his state’s recent legalization of professional psychedelic services, noting how it is “ridiculous” for the FDA to mandate expensive synthetics instead of whole mushrooms:
“There is a lot of promise that some of the mushroom-based therapies (and) natural medicines show for post-traumatic stress disorder, for depression — studies out of Johns Hopkins and others — and we want to make that available…The bureaucracy with the FDA, this stuff takes decades or years, and it comes out costing $1,000 a pill. It’s ridiculous, right? So we want to make this available. It’s promising.”
“The resurgence of scientific research of entheogens, such as psilocybin, has brought to light the immense healing potential for our planet – both on an individual and collective level. For psilocybin to be legally recognized as a medicine would be paradigm shifting for mental healthcare and society in general, whereby people would have a tool for understanding human consciousness such as others have compared before to what the telescope provided for astronomy.”
Erik Bayona, MD,
Board Certified Psychiatrist
“I have witnessed countless testimonies recounting the many benefits of medicinal mushrooms for them . I want to lend my efforts to the legalization of psychedelics so that alternatives to the opioid epidemic might be explored more readily.”
Margaret Linde , BSN , RN,
Licensed Clinical Social Worker and Therapist
“I have struggled with trauma, anxiety, panic disorders, and PTSD for years, trying various therapies with little success. Macrodosing psilocybin in a clinical setting provided me with relief and clarity like nothing else. I believe in the transformative power of this medicine and its potential to help countless others. More of those in need can access this effective treatment.”
Sandy Dorau,
Psychology Student and Veteran